These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27934695)

  • 1. Overview of CRISPR-Cas9 Biology.
    Ratner HK; Sampson TR; Weiss DS
    Cold Spring Harb Protoc; 2016 Dec; 2016(12):pdb.top088849. PubMed ID: 27934695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.
    Westra ER; Levin BR
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):27777-27785. PubMed ID: 33122438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
    Faure G; Shmakov SA; Yan WX; Cheng DR; Scott DA; Peters JE; Makarova KS; Koonin EV
    Nat Rev Microbiol; 2019 Aug; 17(8):513-525. PubMed ID: 31165781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR-Cas system - from bacterial immunity to genome engineering.
    Czarnek M; Bereta J
    Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):901-16. PubMed ID: 27594566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CRISPR-Cas adaptive immune systems.
    Patterson AG; Yevstigneyeva MS; Fineran PC
    Curr Opin Microbiol; 2017 Jun; 37():1-7. PubMed ID: 28359988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back.
    Koonin EV; Makarova KS
    Genome Biol Evol; 2017 Oct; 9(10):2812-2825. PubMed ID: 28985291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
    Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
    Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenomics of Cas4 family nucleases.
    Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
    BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I-F systems.
    Almendros C; Guzmán NM; García-Martínez J; Mojica FJ
    Nat Microbiol; 2016 Jun; 1(8):16081. PubMed ID: 27573106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining CRISPR/Cas9 and natural excision for the precise and complete removal of mobile genetic elements in bacteria.
    Wang P; Du X; Zhao Y; Wang W; Cai T; Tang K; Wang X
    Appl Environ Microbiol; 2024 Apr; 90(4):e0009524. PubMed ID: 38497640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene regulation by engineered CRISPR-Cas systems.
    Fineran PC; Dy RL
    Curr Opin Microbiol; 2014 Apr; 18():83-9. PubMed ID: 24637219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas systems: new players in gene regulation and bacterial physiology.
    Sampson TR; Weiss DS
    Front Cell Infect Microbiol; 2014; 4():37. PubMed ID: 24772391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CRISPR-Cas Immune System and Genetic Transfers: Reaching an Equilibrium.
    Samson JE; Magadan AH; Moineau S
    Microbiol Spectr; 2015 Feb; 3(1):PLAS-0034-2014. PubMed ID: 26104549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.
    Heussler GE; O'Toole GA
    J Bacteriol; 2016 May; 198(10):1481-6. PubMed ID: 26929301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-canonical inhibition strategies and structural basis of anti-CRISPR proteins targeting type I CRISPR-Cas systems.
    Yin P; Zhang Y; Yang L; Feng Y
    J Mol Biol; 2023 Apr; 435(7):167996. PubMed ID: 36754343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.